As part of our unique approach to digestive health, at OneWelbeck we take the treatment of bowel cancer as something which requires the utmost care and attention. Bowel Cancer UK estimates that there are 42,000 new cases of bowel cancer diagnosed every year, and it is one of the most common cancer types in the UK. There are common causes which help specialists like the team at OneWelbeck be well equipped to diagnose and treat bowel cancer. In this brief blog post, we wanted to give some insight into the risk factors of bowel cancer, and how you might go about getting screened before receiving treatment. The most common risk factors of bowel cancer are: age, family history, genetic conditions, history of inflammatory or digestive problems, diabetes and lifestyle.

Written By Dr Boon Lim. Consultant Cardiologist and Electrophysiologist

Professor Mark Westwood is a consultant cardiologist at OneWelbeck Heart Health, specialising in cardiac MRI and cardio-oncology.

Dr. Florian Wernig is a Consultant Endocrinologist at OneWelbeck. He specialises in pituitary, adrenal disorders, thyroid conditions and thyroid cancer, and neuroendocrine tumours. He is a Consultant Endocrinologist at Hammersmith Hospital, Imperial College Healthcare NHS Trust and an Honorary Clinical Senior Lecturer at Imperial College London.

Welbeck Oxford is a new state-of-the-art private healthcare centre that is set to open in Oxford in 2025. The centre will offer a wide range of medical services, including heart health, lung health, digestive health, ENT, endoscopy, and neurology. Welbeck Oxford will be equipped with the latest technology and will focus on providing patient-centred care, with an emphasis on same-day recovery.

Experience exceptional patient care and cutting-edge technology at our new state-of-the-art facility. We are thrilled to announce that Welbeck Health Partners are coming to Cambridge. As a leading provider of private healthcare, we're committed to delivering the best possible patient experience through minimally invasive surgery, outpatient diagnostics, and a comprehensive range of medical services.

Weight Management refers to a continuous procedure by which you will maintain a healthy weight through a variety of methods.

A brand new ‘gamechanging’ drug is set to make waves in the medical world as thousands of people with obesity in England will be able to access Wegovy, Semaglutide, on the NHS. Dr Iqbal Malik, Consultant Cardiologist at OneWelbeck Heart Health, takes a closer look at the drug and its impact. Please note that this drug is not available to patients at OneWelbeck Heart Health.